Consolidated Balance Sheets - USD ($) $ in Millions	Nov. 30, 2022	Feb. 28, 2022
Current
Cash and cash equivalents (note 2)	$ 255	$ 378
Short-term Investments	194	334
Accounts receivable, net of allowance of $5 and $4, respectively (note 3)	131	138
Other receivables (note 3)	9	25
Income taxes receivable	5	9
Other current assets (note 3)	175	159
Assets, Current, Total	769	1,043
Restricted cash and cash equivalents (note 2)	27	28
Long-term investments (note 2)	29	30
Other long-term assets (note 3)	8	9
Operating lease right-of-use assets, net	46	50
Property, plant and equipment, net (note 3)	26	41
Goodwill (note 3)	839	844
Intangible assets, net (note 3)	450	522
Assets	2,194	2,567
Current
Accounts payable	21	22
Accrued liabilities (note 3)	154	157
Income taxes payable (note 4)	21	11
Debentures (note 5)	392	0
Deferred revenue, current (note 10)	179	207
Total current liabilities	767	397
Deferred revenue, non-current (note 10)	30	37
Operating lease liabilities	57	66
Other long-term liabilities	1	4
Long-term debentures (note 5)	0	507
Total liabilities	855	1,011
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 580,346,426 voting common shares (February 28, 2022 - 576,227,898)	2,898	2,869
Deficit	(1,533)	(1,294)
Accumulated other comprehensive loss (note 8)	(26)	(19)
Total shareholders' equity	1,339	1,556
Total liabilities and shareholders' equity	$ 2,194	$ 2,567
Common outstanding (in shares)	580,346,426	576,227,898